Hadasit Bio-Holdings

In the News

Thrombotech Raises $1.4 M and Is Expanding Its Phase IIa Trial

Jan. 10, 2012

The Marker

Globes

Calcalist

Bizportal

Sponser

NRG

 
 

News Archive